Oxurion NV

Research Oxurion NV (OXUR) on Bullrun: market cap EUR 310.94K. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerOXUR
• ExchangeBR
• CountryBelgium
• SectorHealthcare
• IndustryBiotechnology
• CurrencyEUR
• Market capEUR 310.94K
• Financial periodFY2024
• RevenueEUR 3.00K
• Revenue growth-98.9%
• Net incomeEUR 119.00K
• Free cash flow-EUR 2.07M
• Gross margin-1333.3%

Valuation Snapshot

latest market cap is EUR 310.94K.

About Oxurion NV

Oxurion NV, a biopharmaceutical company, develops medicines for vascular retinal disorder in Belgium. The company is developing ophthalmic treatments to preserve vision for patients geographic atrophy and wet age-related macular degeneration. The company was formerly known as ThromboGenics NV and changed its name to Oxurion NV in September 2018. Oxurion NV was founded in 1991 and is headquartered in Leuven, Belgium.

Frequently asked questions

What is Oxurion NV's market cap?

Oxurion NV's market capitalization is EUR 310.94K.

What does Oxurion NV do?

Oxurion NV, a biopharmaceutical company, develops medicines for vascular retinal disorder in Belgium. The company is developing ophthalmic treatments to preserve vision for patients geographic atrophy and wet age-related macular degeneration.